Oncogenic human papillomavirus genital infection in southern Iranian women: Population-based study versus clinic-based data

Virology Journal

Volumn 9, Issue , 2012, Pages

  Eghbali, Seyed Sajjad ^a   Amirinejad, Roya ^a   Obeidi, Narges ^a   Mosadeghzadeh, Shiva ^a   Vahdat, Katayoun ^a   Azizi, Fatemeh ^a   Pazoki, Raha ^a   Sanjdideh, Zahra ^a   Amiri, Zahra ^a   Nabipour, Iraj ^a   Zandi, Keivan ^a,b  

^a BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Bushehr; Cervical cancer; Human papilloma virus; Iran; PCR

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; COMPARATIVE STUDY; FEMALE; FEMALE GENITAL TRACT INFECTION; GENOTYPE; GYNECOLOGIC CARE; HUMAN; IRAN; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PAPILLOMAVIRUS INFECTION; POPULATION RESEARCH; PREVALENCE; TUMOR VIRUS; VIRAL GENETICS; VIRUS CARCINOGENESIS;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IRAN; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; REPRODUCTIVE TRACT INFECTIONS; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 84866022628     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-194     Document Type: Article

References (33)

1. Effective screening programmes for cervical cancer in low-and middle-income developing countries. Sankaranarayanan R, Budukh AM, Rajkumar R, Bull World Health Organ 2001 79 954 962 11693978
2. Age-specific prevalence of infection with human papillomavirus in females: a global review. Smith JS, Melendy A, Rana RK, Pimenta JM, J Adolescent Health 2008 43 5 25
3. Centers for Disease Control and Prevention, Human papillomavirus: HPV information for clinicians 2007
4. Epidemiologic classification of human papillomavirus types associated with cervical cancer. Mũoz N, Bosch FX, De Sanjosé S, et al. N Engl J Med 2003 348 518 527 10.1056/NEJMoa021641 12571259
5. Genital human papillomavirus infection. Lowy DR, Kirnbauer R, Schiller JT, Proc Natl Acad Sci 1994 91 2436 2440 10.1073/pnas.91.7.2436 8146136
6. Human papillomaviruses and associated malignancies. Alani RM, Munger K, J Clin Oncol 1998 16 330 337 9440761
7. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Mũoz N, J Pathol 1999 189 12 19 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F 10451482
8. A survey on the prevalence of high-risk subtypes of human papilloma virus among women with cervical neoplasia in Isfahan University of Medical Science. Allameh T, Moghim S, Asadi-Zeidabadi M, Arch Gynecol Obstet 2011 284 1509 1513 10.1007/s00404-011-1863-4 21387088
9. The prevalence of human papillomavirus in cervical cancer in Iran. Mortazavi S, Zali M, Raoufi M, Nadji M, Kowsarian P, Nowroozi A, Asian Pac J Cancer Prev 2002 3 69 72 12718611
10. High risk HPV types in southern Iranian patients with cervical cancer. Farjadian S, Asadi E, Doroudchi M, et al. Pathol Oncol Res 2003 9 121 125 10.1007/BF03033756 12858218
11. Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran. Ghaffari SR, Sabokbar T, Mollahajian H, et al. Asian Pac J Cancer Prev 2006 7 529 532 17250423
12. Prevalence of various Human Papillomavirus (HPV) genotypes among women who subjected to routine Pap smear test in Bushehr city (South west of Iran) 2008-2009. Zandi K, Eghbali SS, Hamkar R, et al. Virol J 2010 7 1 4 10.1186/1743-422X-7-1 20044930
13. Prevalence of HPV Infection and Its Association with Cytological Abnormalities of Pap Smears in Tehran. Zavarei MJZJ, Hamkar R, Dana VG, Delforoosh M, Shojamoradi M, Gilani MM, Iranian J Public Health 2008 37 101 106
14. Prevalence of high-risk human papillomavirus types 16 and 18 in healthy women with cytologically negative pap smear in Iran. Safaei A, Khanlari M, Momtahen M, et al. Indian J Pathol Microbiol 2010 53 681 685 10.4103/0377-4929.72030 21045392
15. Human papillomavirus infection in women with and without cervical cancer in Tehran, Iran. Khodakarami N, Clifford GM, Yavari P, Farzaneh F, Salehpour S, Broutet N, Bathija H, Heideman DA, van Kemenade FJ, Meijer CJ, Hosseini SJ, Franceschi S, Int J Cancer 2012 131 156 E161 10.1002/ijc.26488 22038830
16. World Health Organization/ICO Information Center on HPV and Cervical Cancer (HPV Information Center), Human papillomavirus and related cancers. Summary Report Update 2010
17. Prevalence of various types of Human Papillomavirus among cervical cancer and normal biopsy specimens in the Mazandaran province of Iran. Hamkar R, Mokhtari-Azad T, et al. Eastern Mediterr Health J 2002 6 805 811
18. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Sankaranarayanan R, Budukh AM, Rajkumar R, Bull World Health Org 2001 79 10
19. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test. Van Hamont D, Van Ham MA, Bakkers JM, Massuger LF, Melchers WJ, J Clin Microbiol 2006 44 3122 3129 10.1128/JCM.00517-06 16954236
20. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S, J Infect Dis 2010 202 1789 1799 10.1086/657321 21067372
21. The epidemiology of genital human papillomavirus infection. Trottier H, Franco EL, Vaccine 2006 24 suppl 1 1 15 16122853
22. Burden of human papillomavirus-related cervical disease in the extended middle East and north Africa-a comprehensive literature review. Seoud M, J Low Genit Tract Dis 2012 16 106 120 10.1097/LGT.0b013e31823a0108 22371041
23. Prevalence of human papillomavirus among women with normal cervical cytology in Kuwait. Al-Awadhi R, Chehadeh W, Kapila K, J Med Virol 2011 83 453 460 10.1002/jmv.21981 21264866
24. Prevalence and type distribution of highrisk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. Agarossi A, Ferrazzi E, Parazzini F, Perno CF, Ghisoni L, J Med Virol 2009 81 529 535 10.1002/jmv.21347 19152401
25. Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study. Rossi PG, Bisanzi S, Paganini I, et al. BMC Infect Dis 2010 10 214 20646310
26. Comparison of adult HIV prevalence from national population -based surveys and antenatal clinic surveillance in countries with generalised epidemics: implications for calibrating surveillance data. Gouws E, Mishra V, Fowler TB, Sex Transm Infect 2008 84 17 23 10.1136/sti.2007.026815 17728340
27. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Clifford GM, Gallus S, Herrero R, Mũoz N, Snijders PJF, Vaccarella S, Anh PTH, Ferreccio C, Hieu NT, Matos E, et al. Lancet 2005 366 991 998 10.1016/S0140-6736(05)67069-9 16168781
28. Prevalence of single and multiple HPV types in cervical carcinomas in Jakarta, Indonesia. Schellekens MC, Dijkman A, Aziz MF, et al. Gynecol Oncol 2004 93 49 53 10.1016/j.ygyno.2003.12.015 15047213
29. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S, Br J Cancer 2003 88 63 73 10.1038/sj.bjc.6600688 12556961
30. Prevalence and incidence of human papillomavirus infection in women in the USA: a systematic review. Revzina NV, Diclemente RJ, Int J STD AIDS 2005 16 528 537 10.1258/0956462054679214 16105186
31. Prevalence of cervical neoplastic lesions and human papilloma virus infection in Egypt: national cervical cancer screening project. El-All HS, Refaat A, Dandash K, Infectious Agents and Cancer 2007 2 12 10.1186/1750-9378-2- 12 17610742
32. Pattern of cervical smear cytology in the western region of Saudia Arabia. Altaf FJ, Annals Saudi Med 2001 21 94 96
33. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Wright TC, Schiffman M, Solomon D, et al. Obstet Gynecol 2004 103 304 309 10.1097/01.AOG.0000109426.82624.f8 14754700